iTeos Therapeutics, Inc. Annual Operating Margin in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
iTeos Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2021 to 2023.
  • iTeos Therapeutics, Inc. Operating Margin for the quarter ending June 30, 2024 was -414 %, a 445% decline year-over-year.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2023 was -1.2K %, a 2642% decline from 2022.
  • iTeos Therapeutics, Inc. annual Operating Margin for 2022 was 47.2 %, a 33.5% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -1.2K -1.25K -2642% Jan 1, 2023 Dec 31, 2023
2022 47.2 -23.8 -33.5% Jan 1, 2022 Dec 31, 2022
2021 71 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.